Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/11133
Title: Highly selective anthraquinone-chalcone hybrids as potential antileukemia agents
Authors: Stanojkovic, Tatjana
Marković, Violeta
Matic, Ivana
Mladenović M.
Petrovic, Nina
Krivokuca, Ana
Petkovic, Milos
Joksović, Milan
Journal: Bioorganic and Medicinal Chemistry Letters
Issue Date: 15-Aug-2018
Abstract: © 2018 Elsevier Ltd A series of 23 novel anthraquinone-chalcone hybrids containing amide function was synthesized and structurally characterized. Sixteen compounds exerted strong cytotoxic activities against K562, Jurkat and HL-60 leukemia cell lines and significantly lower cytotoxic effects against normal MRC-5 cells, indicating very high selectivity in their anticancer action. The compounds 6g, 6u and 6v activate apoptosis in K562 cells through the extrinsic and intrinsic apoptotic pathway. The compound 6e triggered apoptosis in K562 cells only through the extrinsic apoptotic pathway. Treatment of K562 cells with each of these four compounds caused decrease in the expression levels of MMP2, MMP9, and VEGF, suggesting their anti-invasive, antimetastatic and antiangiogenic properties. The compounds 6g and 6v downregulated expression levels of miR-155 in K562 cells, while compounds 6e and 6u upregulated miR-155 levels in treated cells, in comparison with control cells. The structure-based 3-D QSAR models for 6f, 6e, 6i and 6l describe pro-apoptotic activity against caspase-3.
URI: https://scidar.kg.ac.rs/handle/123456789/11133
Type: Article
DOI: 10.1016/j.bmcl.2018.06.048
ISSN: 0960894X
SCOPUS: 85049322460
Appears in Collections:Faculty of Science, Kragujevac
[ Google Scholar ]

Page views(s)

18

Files in This Item:
File Description SizeFormat 
PaperMissing.pdf
  Restricted Access
29.86 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.